Sichuan Huiyu Pharmaceutical Hits Day Low Amid Price Pressure at CNY 16.16

Sichuan Huiyu Pharmaceutical Co., Ltd. experienced significant volatility today, with the stock declining by 7.45% as it reached an intraday low of CNY 16.16. This performance starkly contrasts with the broader market, as the China Shanghai Composite index fell only 1.24% during the same period. Over the past week, Sichuan Huiyu's stock has dropped 11.31%, and its monthly performance shows a decline of 15.83%. Year-to-date, the stock has decreased by 9.16%, while its one-year performance reflects a loss of 2.42%, significantly underperforming the China Shanghai Composite, which has gained 16.08% over the same timeframe. Financial metrics indicate challenges for the company, with net sales declining at an annual rate of 15.85% and operating profit plummeting by 139.44% over the last five years. Recent half-year results also show a decrease in net sales by 17.49% and a net profit drop of 31.32%. The company’s return on equity stands at a modest 2.20%, further highlighting its current market position within the pharmaceuticals and biotechnology sector.